David Lebovitz is a prominent Global Strategist at J.P. Morgan Asset Management, specializing in Multi-Asset Solutions. With a comprehensive understanding of global markets and alternative investments, David brings valuable insights into the dynamic world of biotech. In this episode, he is joined by Dr. Stephen Squinto, Chief Investment Officer of J.P. Morgan Life Sciences Private Capital. Dr. Squinto, a seasoned expert in biotechnology and life sciences investment, shares his extensive knowledge on the private biotech market, highlighting the challenges and opportunities that lie ahead in 2024 and beyond. With a focus on market themes, M&A activities, and valuations, their discussion provides a thorough exploration of the biotech sector, offering investors a strategic perspective on navigating this innovative and rapidly evolving field.